Trial Profile
A Phase 1, Open-label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of [14C]-SHP626 Following a Single Oral Dose in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Volixibat (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Shire
- 12 Jul 2017 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 14 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 14 Oct 2015 New trial record